Intraumbilical vein injection of prostaglandin F2α in retained placenta
- 1 January 1996
- journal article
- clinical trial
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 64 (1) , 59-61
- https://doi.org/10.1016/0301-2115(95)02273-2
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Umbilical vein administration of oxytocin for the management of retained placenta: Is it effective?American Journal of Obstetrics and Gynecology, 1991
- Management of retained placenta by umbilical vein injectionBJOG: An International Journal of Obstetrics and Gynaecology, 1991
- Removing a retained placenta by oxytocin—A controlled studyAmerican Journal of Obstetrics and Gynecology, 1989
- Intra-umbilical vein oxytocin in the management of retained placenta: a random, prospective, double blind, placebo controlled studyJournal of Obstetrics and Gynaecology, 1988
- Influence of umbilical vein administration of oxytocin on the third stage of labor: A randomized, double-blind, placebo-controlled studyAmerican Journal of Obstetrics and Gynecology, 1987
- The effect of oxytocin injection into the umbilical vein for the management of the retained placentaAmerican Journal of Obstetrics and Gynecology, 1987
- Oxytocin injection into the umbilical vein in women with retained placenta: A questionable methodAmerican Journal of Obstetrics and Gynecology, 1986
- Intra-umbilical vein oxytocin in the management of retained placenta. A double blind placebo controlled studyJournal of Obstetrics and Gynaecology, 1986
- A new method for the management of the retained placentaAmerican Journal of Obstetrics and Gynecology, 1983